Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Technical Detail for Robot Assisted Pancreaticoduodenectomy.

Kim AC, Rist RC, Zureikat AH.

J Vis Exp. 2019 Sep 28;(151). doi: 10.3791/60261.

PMID:
31609339
2.

The Miami International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection.

Asbun HJ, Moekotte AL, Vissers FL, Kunzler F, Cipriani F, Alseidi A, D'Angelica MI, Balduzzi A, Bassi C, Björnsson B, Boggi U, Callery MP, Del Chiaro M, Coimbra FJ, Conrad C, Cook A, Coppola A, Dervenis C, Dokmak S, Edil BH, Edwin B, Giulianotti PC, Han HS, Hansen PD, van der Heijde N, van Hilst J, Hester CA, Hogg ME, Jarufe N, Jeyarajah DR, Keck T, Kim SC, Khatkov IE, Kokudo N, Kooby DA, Korrel M, de Leon FJ, Lluis N, Lof S, Machado MA, Demartines N, Martinie JB, Merchant NB, Molenaar IQ, Moravek C, Mou YP, Nakamura M, Nealon WH, Palanivelu C, Pessaux P, Pitt HA, Polanco PM, Primrose JN, Rawashdeh A, Sanford DE, Senthilnathan P, Shrikhande SV, Stauffer JA, Takaori K, Talamonti MS, Tang CN, Vollmer CM, Wakabayashi G, Walsh RM, Wang SE, Zinner MJ, Wolfgang CL, Zureikat AH, Zwart MJ, Conlon KC, Kendrick ML, Zeh HJ, Hilal MA, Besselink MG; International Study Group on Minimally Invasive Pancreas Surgery (I-MIPS).

Ann Surg. 2019 Sep 16. doi: 10.1097/SLA.0000000000003590. [Epub ahead of print]

PMID:
31567509
3.

Does Preoperative MELD Score Predict Adverse Outcomes Following Pancreatic Resection: an ACS NSQIP Analysis.

Al Abbas AI, Borrebach JD, Bellon J, Zureikat AH.

J Gastrointest Surg. 2019 Aug 29. doi: 10.1007/s11605-019-04380-0. [Epub ahead of print]

PMID:
31468333
4.

Intrathecal Morphine Versus Nerve Blocks in an Enhanced Recovery Pathway for Pancreatic Surgery.

Boisen ML, McQuaid AJ, Esper SA, Holder-Murray J, Zureikat AH, Hogg ME, Paronish J, Subramaniam K.

J Surg Res. 2019 Jul 3;244:15-22. doi: 10.1016/j.jss.2019.05.049. [Epub ahead of print]

PMID:
31279259
5.

Robotic Pancreaticoduodenectomy Is Associated with Decreased Clinically Relevant Pancreatic Fistulas: a Propensity-Matched Analysis.

Cai J, Ramanathan R, Zenati MS, Al Abbas A, Hogg ME, Zeh HJ, Zureikat AH.

J Gastrointest Surg. 2019 Jul 2. doi: 10.1007/s11605-019-04274-1. [Epub ahead of print]

PMID:
31267434
6.

Comprehensive comparative analysis of cost-effectiveness and perioperative outcomes between open, laparoscopic, and robotic distal pancreatectomy.

Magge DR, Zenati MS, Hamad A, Rieser C, Zureikat AH, Zeh HJ, Hogg ME.

HPB (Oxford). 2018 Dec;20(12):1172-1180. doi: 10.1016/j.hpb.2018.05.014. Epub 2018 Jun 30.

PMID:
31217087
7.

How I Do It: Robotic Pancreaticoduodenectomy.

Wilson GC, Zeh HJ 3rd, Zureikat AH.

J Gastrointest Surg. 2019 Aug;23(8):1661-1671. doi: 10.1007/s11605-019-04266-1. Epub 2019 May 30. No abstract available.

PMID:
31147974
8.

Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.

Ecker BL, Vollmer CM Jr, Behrman SW, Allegrini V, Aversa J, Ball CG, Barrows CE, Berger AC, Cagigas MN, Christein JD, Dixon E, Fisher WE, Freedman-Weiss M, Guzman-Pruneda F, Hollis RH, House MG, Kent TS, Kowalsky SJ, Malleo G, Salem RR, Salvia R, Schmidt CR, Seykora TF, Zheng R, Zureikat AH, Dickson PV.

JAMA Surg. 2019 May 29. doi: 10.1001/jamasurg.2019.1170. [Epub ahead of print]

PMID:
31141112
9.

A Combination of Robotic Approach and ERAS Pathway Optimizes Outcomes and Cost for Pancreatoduodenectomy.

Kowalsky SJ, Zenati MS, Steve J, Esper SA, Lee KK, Hogg ME, Zeh HJ 3rd, Zureikat AH.

Ann Surg. 2019 Jun;269(6):1138-1145. doi: 10.1097/SLA.0000000000002707.

PMID:
31082913
10.

Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures.

Singhi AD, Nikiforova MN, Chennat J, Papachristou GI, Khalid A, Rabinovitz M, Das R, Sarkaria S, Ayasso MS, Wald AI, Monaco SE, Nalesnik M, Ohori NP, Geller D, Tsung A, Zureikat AH, Zeh H, Marsh JW, Hogg M, Lee K, Bartlett DL, Pingpank JF, Humar A, Bahary N, Dasyam AK, Brand R, Fasanella KE, McGrath K, Slivka A.

Gut. 2019 Apr 10. pii: gutjnl-2018-317817. doi: 10.1136/gutjnl-2018-317817. [Epub ahead of print]

11.

Appleby Procedure (Distal Pancreatectomy With Celiac Artery Resection) for Locally Advanced Pancreatic Carcinoma: Indications, Outcomes, and Imaging.

Cannella R, Borhani AA, Zureikat AH, Tublin ME.

AJR Am J Roentgenol. 2019 Mar 27:1-10. doi: 10.2214/AJR.18.20887. [Epub ahead of print]

PMID:
30917026
12.

Robotic pancreatoduodenectomy with vascular resection: Outcomes and learning curve.

Beane JD, Zenati M, Hamad A, Hogg ME, Zeh HJ 3rd, Zureikat AH.

Surgery. 2019 Jul;166(1):8-14. doi: 10.1016/j.surg.2019.01.037. Epub 2019 Mar 21.

PMID:
30905468
13.

Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.

Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, Klempner SJ, Hendifar A, Milind JM, Golan T, Brand RE, Zureikat AH, Roy S, Schrock AB, Miller VA, Ross JS, Ali SM, Bahary N.

Gastroenterology. 2019 Jun;156(8):2242-2253.e4. doi: 10.1053/j.gastro.2019.02.037. Epub 2019 Mar 2.

14.

Methodology for Developing an Educational and Research Video Library in Minimally Invasive Surgery.

Al Abbas AI, Jung JP, Rice MK, Zureikat AH, Zeh HJ 3rd, Hogg ME.

J Surg Educ. 2019 May - Jun;76(3):745-755. doi: 10.1016/j.jsurg.2018.10.011. Epub 2019 Feb 19.

PMID:
30792160
15.

Enhanced Neutrophil Extracellular Trap Formation in Acute Pancreatitis Contributes to Disease Severity and Is Reduced by Chloroquine.

Murthy P, Singhi AD, Ross MA, Loughran P, Paragomi P, Papachristou GI, Whitcomb DC, Zureikat AH, Lotze MT, Zeh Iii HJ, Boone BA.

Front Immunol. 2019 Jan 24;10:28. doi: 10.3389/fimmu.2019.00028. eCollection 2019.

16.

Robotic Inguinal Hernia Repair: A Large Health System's Experience With the First 300 Cases and Review of the Literature.

Tam V, Rogers DE, Al-Abbas A, Borrebach J, Dunn SA, Zureikat AH, Zeh HJ 3rd, Hogg ME.

J Surg Res. 2019 Mar;235:98-104. doi: 10.1016/j.jss.2018.09.070. Epub 2018 Oct 25.

PMID:
30691857
17.

Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection.

Boone BA, Zenati MS, Rieser C, Hamad A, Al-Abbas A, Zureikat AH, Hogg ME, Neal MD, Zeh HJ 3rd.

Ann Surg Oncol. 2019 May;26(5):1503-1511. doi: 10.1245/s10434-018-07148-z. Epub 2019 Jan 16.

PMID:
30652227
18.

Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis.

Klompmaker S, Peters NA, van Hilst J, Bassi C, Boggi U, Busch OR, Niesen W, Van Gulik TM, Javed AA, Kleeff J, Kawai M, Lesurtel M, Lombardo C, Moser AJ, Okada KI, Popescu I, Prasad R, Salvia R, Sauvanet A, Sturesson C, Weiss MJ, Zeh HJ, Zureikat AH, Yamaue H, Wolfgang CL, Hogg ME, Besselink MG; E-AHPBA DP-CAR study group.

Ann Surg Oncol. 2019 Mar;26(3):772-781. doi: 10.1245/s10434-018-07101-0. Epub 2019 Jan 4.

19.

Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant Imatinib.

Brown JB, Pai RK, Burgess MA, Chennat J, Zureikat AH.

J Natl Compr Canc Netw. 2018 Dec;16(12):1424-1428. doi: 10.6004/jnccn.2018.7063.

PMID:
30545989
20.

Correction to: Evolution of a Novel Robotic Training Curriculum in a Complex General Surgical Oncology Fellowship.

Knab LM, Zenati MS, Khodakov A, Rice M, Al-Abbas A, Bartlett DL, Zureikat AH, Zeh HJ, Hogg ME.

Ann Surg Oncol. 2018 Dec 12. doi: 10.1245/s10434-018-07106-9. [Epub ahead of print]

PMID:
30542838
21.

Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in pancreatic adenocarcinoma?

Jung JP, Zenati MS, Hamad A, Hogg ME, Simmons RL, Zureikat AH, Zeh HJ, Boone BA.

HPB (Oxford). 2019 Jun;21(6):679-686. doi: 10.1016/j.hpb.2018.10.012. Epub 2018 Nov 28.

PMID:
30501987
22.

Does robotic pancreaticoduodenectomy improve outcomes in patients with high risk morphometric features compared to the open approach.

Varley PR, Zenati MS, Klobuka A, Tobler J, Hamad A, Hogg ME, Zeh HJ 3rd, Borhani AA, Zureikat AH.

HPB (Oxford). 2019 Jun;21(6):695-701. doi: 10.1016/j.hpb.2018.10.016. Epub 2018 Dec 1.

PMID:
30509562
23.

Crowdsourced Assessment of Inanimate Biotissue Drills: A Valid and Cost-Effective Way to Evaluate Surgical Trainees.

Rice MK, Zenati MS, Novak SM, Al Abbas AI, Zureikat AH, Zeh HJ 3rd, Hogg ME.

J Surg Educ. 2019 May - Jun;76(3):814-823. doi: 10.1016/j.jsurg.2018.10.007. Epub 2018 Nov 22.

PMID:
30472061
24.

Robotic gastrointestinal surgery.

Felder SI, Ramanathan R, Russo AE, Jimenez-Rodriguez RM, Hogg ME, Zureikat AH, Strong VE, Zeh HJ, Weiser MR.

Curr Probl Surg. 2018 Jun;55(6):198-246. doi: 10.1067/j.cpsurg.2018.07.001. Epub 2018 Aug 8. Review. No abstract available.

25.

ASO Author Reflections: Hepatic Artery Infusion (HAI) Chemotherapy is Associated with Improved Survival Compared with Radioembolization (Y90) in Patients with Isolated Unresectable Colorectal Liver Metastases.

Dhir M, Zureikat AH.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):782-783. doi: 10.1245/s10434-018-6834-6. Epub 2018 Oct 8. No abstract available.

PMID:
30298325
26.

ASO Author Reflections: Neoadjuvant Treatment of Resectable and Borderline-Resectable Pancreatic Head Adenocarcinoma: Is FOLFIRINOX Better than Gem/Nab-Paclitaxel?

Dhir M, Zureikat AH.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):808-809. doi: 10.1245/s10434-018-6833-7. Epub 2018 Oct 8. No abstract available.

PMID:
30298324
27.

Evolution of a Novel Robotic Training Curriculum in a Complex General Surgical Oncology Fellowship.

Mark Knab L, Zenati MS, Khodakov A, Rice M, Al-Abbas A, Bartlett DL, Zureikat AH, Zeh HJ, Hogg ME.

Ann Surg Oncol. 2018 Nov;25(12):3445-3452. doi: 10.1245/s10434-018-6686-0. Epub 2018 Aug 2. Erratum in: Ann Surg Oncol. 2018 Dec 12;:.

PMID:
30073601
28.

Use of Video Review to Investigate Technical Factors That May Be Associated With Delayed Gastric Emptying After Pancreaticoduodenectomy.

Jung JP, Zenati MS, Dhir M, Zureikat AH, Zeh HJ, Simmons RL, Hogg ME.

JAMA Surg. 2018 Oct 1;153(10):918-927. doi: 10.1001/jamasurg.2018.2089.

29.

Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier Age.

Chao DT, Shah NH, Zeh HJ 3rd, Singhi AD, Bahary N, McGrath KM, Fasanella KE, Zureikat AH, Whitcomb DC, Brand RE.

Gastroenterol Res Pract. 2018 Jun 5;2018:2380596. doi: 10.1155/2018/2380596. eCollection 2018.

30.

CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time.

Rieser CJ, Zenati M, Hamad A, Al Abbas AI, Bahary N, Zureikat AH, Zeh HJ 3rd, Hogg ME.

Ann Surg Oncol. 2018 Nov;25(12):3483-3491. doi: 10.1245/s10434-018-6521-7. Epub 2018 May 21.

PMID:
29786131
31.

FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma.

Dhir M, Zenati MS, Hamad A, Singhi AD, Bahary N, Hogg ME, Zeh HJ 3rd, Zureikat AH.

Ann Surg Oncol. 2018 Jul;25(7):1896-1903. doi: 10.1245/s10434-018-6512-8. Epub 2018 May 14.

PMID:
29761331
32.

Health Disparities Impact Expected Treatment of Pancreatic Ductal Adenocarcinoma Nationally.

Lutfi W, Zenati MS, Zureikat AH, Zeh HJ, Hogg ME.

Ann Surg Oncol. 2018 Jul;25(7):1860-1867. doi: 10.1245/s10434-018-6487-5. Epub 2018 Apr 24.

PMID:
29691733
33.

Fitbit step counts during inpatient recovery from cancer surgery as a predictor of readmission.

Low CA, Bovbjerg DH, Ahrendt S, Choudry MH, Holtzman M, Jones HL, Pingpank JF Jr, Ramalingam L, Zeh HJ 3rd, Zureikat AH, Bartlett DL.

Ann Behav Med. 2018 Jan 5;52(1):88-92. doi: 10.1093/abm/kax022.

34.

Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.

Roy S, LaFramboise WA, Liu TC, Cao D, Luvison A, Miller C, Lyons MA, O'Sullivan RJ, Zureikat AH, Hogg ME, Tsung A, Lee KK, Bahary N, Brand RE, Chennat JS, Fasanella KE, McGrath K, Nikiforova MN, Papachristou GI, Slivka A, Zeh HJ, Singhi AD.

Gastroenterology. 2018 Jun;154(8):2060-2063.e8. doi: 10.1053/j.gastro.2018.02.026. Epub 2018 Mar 2.

35.

A Combination of Robotic Approach and ERAS Pathway Optimizes Outcomes and Cost for Pancreatoduodenectomy.

Kowalsky SJ, Zenati MS, Steve J, Esper SA, Lee KK, Hogg ME, Zeh HJ 3rd, Zureikat AH.

Ann Surg. 2018 Feb 16. doi: 10.1097/SLA.0000000000002707. [Epub ahead of print]

PMID:
29462006
36.

Robotic pancreatoduodenectomy at an experienced institution is not associated with an increased risk of post-pancreatic hemorrhage.

Magge D, Zenati M, Lutfi W, Hamad A, Zureikat AH, Zeh HJ, Hogg ME.

HPB (Oxford). 2018 May;20(5):448-455. doi: 10.1016/j.hpb.2017.11.005. Epub 2018 Feb 1.

37.

Robotic distal pancreatectomy combined with celiac axis resection.

Greer J, Zureikat AH.

J Vis Surg. 2017 Oct 18;3:145. doi: 10.21037/jovs.2017.08.18. eCollection 2017. Review.

38.

Safety and feasibility of the robotic platform in the management of surgical sequelae of chronic pancreatitis.

Hamad A, Zenati MS, Nguyen TK, Hogg ME, Zeh HJ 3rd, Zureikat AH.

Surg Endosc. 2018 Feb;32(2):1056-1065. doi: 10.1007/s00464-017-6010-2. Epub 2017 Dec 22.

PMID:
29273874
39.

Postoperative narcotic use is associated with development of clinically relevant pancreatic fistulas after distal pancreatectomy.

Kowalsky SJ, Zenati MS, Dhir M, Schaefer EG, Dopsovic A, Lee KK, Hogg ME, Zeh HJ, Vollmer CM, Zureikat AH.

Surgery. 2018 Apr;163(4):747-752. doi: 10.1016/j.surg.2017.10.042. Epub 2017 Dec 18.

PMID:
29269087
40.

Ketorolac use may increase risk of postoperative pancreatic fistula after pancreaticoduodenectomy.

Kowalsky SJ, Zenati MS, Steve J, Lee KK, Hogg ME, Zeh HJ 3rd, Zureikat AH.

J Surg Res. 2018 Jan;221:43-48. doi: 10.1016/j.jss.2017.08.006.

PMID:
29229151
41.

Assessing the impact of conversion on outcomes of minimally invasive distal pancreatectomy and pancreatoduodenectomy.

Beane JD, Pitt HA, Dolejs SC, Hogg ME, Zeh HJ, Zureikat AH.

HPB (Oxford). 2018 Apr;20(4):356-363. doi: 10.1016/j.hpb.2017.10.007. Epub 2017 Nov 27.

42.

Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM).

Dhir M, Zenati MS, Jones HL, Bartlett DL, Choudry MHA, Pingpank JF, Holtzman MP, Bahary N, Hogg ME, Zeh HJ 3rd, Geller DA, Wallis Marsh J, Tsung A, Zureikat AH.

Ann Surg Oncol. 2018 Feb;25(2):550-557. doi: 10.1245/s10434-017-6265-9. Epub 2017 Nov 27.

PMID:
29181682
43.

Resident attitudes and compliance towards robotic surgical training.

Tam V, Lutfi W, Novak S, Hamad A, Lee KK, Zureikat AH, Zeh HJ 3rd, Hogg ME.

Am J Surg. 2018 Feb;215(2):282-287. doi: 10.1016/j.amjsurg.2017.08.051. Epub 2017 Nov 14.

PMID:
29174164
44.

Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei.

Choudry HA, Pai RK, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL.

Ann Surg Oncol. 2018 Jan;25(1):76-82. doi: 10.1245/s10434-017-6214-7. Epub 2017 Nov 6.

PMID:
29110275
45.

Surgical Resection Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical Resection with Intra-Arterial Therapies.

Wright GP, Perkins S, Jones H, Zureikat AH, Marsh JW, Holtzman MP, Zeh HJ 3rd, Bartlett DL, Pingpank JF Jr.

Ann Surg Oncol. 2018 Jan;25(1):83-90. doi: 10.1245/s10434-017-6110-1. Epub 2017 Oct 23.

PMID:
29063296
46.

Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion.

Pakraftar S, Ramalingam L, Shuai Y, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA.

Ann Surg Oncol. 2017 Dec;24(13):3811-3817. doi: 10.1245/s10434-017-6114-x. Epub 2017 Oct 10.

PMID:
29019111
47.

Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.

Singhi AD, McGrath K, Brand RE, Khalid A, Zeh HJ, Chennat JS, Fasanella KE, Papachristou GI, Slivka A, Bartlett DL, Dasyam AK, Hogg M, Lee KK, Marsh JW, Monaco SE, Ohori NP, Pingpank JF, Tsung A, Zureikat AH, Wald AI, Nikiforova MN.

Gut. 2018 Dec;67(12):2131-2141. doi: 10.1136/gutjnl-2016-313586. Epub 2017 Sep 28.

48.

Factors associated with prolonged hospitalization in patients undergoing pancreatoduodenectomy.

Radomski M, Zenati M, Novak S, Tam V, Steve J, Bartlett DL, Zureikat AH, Zeh HJ 3rd, Hogg ME.

Am J Surg. 2018 Apr;215(4):636-642. doi: 10.1016/j.amjsurg.2017.06.040. Epub 2017 Sep 18.

PMID:
28958654
49.

Towards standardized robotic surgery in gastrointestinal oncology.

Knab LM, Zureikat AH, Zeh HJ 3rd, Hogg ME.

Langenbecks Arch Surg. 2017 Nov;402(7):1003-1014. doi: 10.1007/s00423-017-1623-4. Epub 2017 Sep 27. Review.

PMID:
28956165
50.

Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation.

Maggino L, Malleo G, Bassi C, Allegrini V, Beane JD, Beckman RM, Chen B, Dickson EJ, Drebin JA, Ecker BL, Fraker DL, House MG, Jamieson NB, Javed AA, Kowalsky SJ, Lee MK, McMillan MT, Roses RE, Salvia R, Valero V 3rd, Velu LKP, Wolfgang CL, Zureikat AH, Vollmer CM Jr.

Ann Surg. 2019 Feb;269(2):337-343. doi: 10.1097/SLA.0000000000002532.

PMID:
28938266

Supplemental Content

Loading ...
Support Center